R. Pinkerton

A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours

D. Frappaz, G. Vassal, J. Robert, 2006, British Journal of Cancer.

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL Rl trial

S. Lawson, O. Eden, G. Harrison, 2005 .

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party.

S. Richards, S. Lawson, O. Eden, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Etoposide in relapsed or refractory Wilms' tumor: a phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.

G. Levitt, G. Margueritte, M. Tournade, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase I/II Study of Trimetrexate and Capecitabine in Patients With Advanced Refractory Colorectal Cancer

S. Wieand, T. Richards, K. Matin, 2005, American journal of clinical oncology.

Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer.

M. Fakih, B. Carneiro, B. Lembersky, 2012, Clinical colorectal cancer.

Phase II study of 21 day schedule oral etoposide in children

S. Lowis, A. Davidson, R. Pinkerton, 1997 .

Phase II study of bevacizumab (BEV), weekly (wkly) intermittent capecitabine (Cap), and oxaliplatin (Ox) on an every-2-week schedule for patients (Pts) with untreated advanced colorectal cancer (CRC)

B. Lembersky, D. Potter, R. Sehgal, 2008 .

A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer.

H. Zeh, B. Lembersky, R. Ramanathan, 2011, Clinical colorectal cancer.

A Randomized Clinical Trial of Lenalidomide and Dexamethasone with and without Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma: Interim Study Results

G. Roodman, M. Abbas, D. Normolle, 2011 .